logo    Company Page

Most Recent Insiders Activity

Transaction Date Company Name Insider Name (Title) Activity Stock Acquired or Disposed Shares Price range Amount
2024-11-14 Theravance Biopharma, Inc. Winningham Rick E
(CHIEF EXECUTIVE OFFICER)
A Ordinary Shares A 3193 $9.57 - $9.57 $30,557
2024-11-11 Theravance Biopharma, Inc. Farnum Rhonda
(SVP, COMM & MEDICAL AFFAIRS)
S Ordinary Shares D 4000 $9.00 - $9.00 $36,000
2024-08-20 Theravance Biopharma, Inc. Winningham Rick E
(CHIEF EXECUTIVE OFFICER)
F Ordinary Shares D 15997 $8.22 - $8.22 $131,495
2024-08-20 Theravance Biopharma, Inc. Sawaf Aziz
(SVP & CHIEF FINANCIAL OFFICER)
F Ordinary Shares D 8635 $8.22 - $8.22 $70,979
2024-08-20 Theravance Biopharma, Inc. Miller Aine
(SVP, DEV & HEAD OF IRE OFFICE)
F Ordinary Shares D 5201 $8.22 - $8.22 $42,752
2024-08-20 Theravance Biopharma, Inc. Grimaud Brett A.
(SVP, GEN COUNSEL AND SECRETARY)
F Ordinary Shares D 9268 $8.22 - $8.22 $76,182
2024-08-20 Theravance Biopharma, Inc. Farnum Rhonda
(SVP, COMM & MEDICAL AFFAIRS)
F Ordinary Shares D 9222 $8.22 - $8.22 $75,804
2024-08-07 Theravance Biopharma, Inc. Winningham Rick E
(CHIEF EXECUTIVE OFFICER)
A Ordinary Shares A 3252 $7.83 - $7.83 $25,463
2024-08-07 Theravance Biopharma, Inc. Samaha Eli
(AtLeastTenPercentOwner)
P COM A 999800 $7.80 - $7.80 $7,798,440
2024-07-10 Theravance Biopharma, Inc. Farnum Rhonda
(SVP, COMM & MEDICAL AFFAIRS)
S Ordinary Shares D 4000 $9.00 - $9.00 $36,000
logo   

Please upgrade to premium to see all results. Signup if you don't have an account.

Login Signup
Activity types
A Grant, award or other acquisition
C Conversion of Derivative or Security
D Disposition to the issuer of issuer equity securities
E Expiration of short derivative position
F Payment of exercise price or tax liability
G Bona fide Gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary Transaction
J Other acquisition or disposition
K Transaction in equity swap or instrument with similar characteristics
L Small Acquisition
M Exercise or conversion of derivative security
O Exercise of out-of-the-money derivative security
P Open Market Purchase
S Open Market Sale
U Disposition pursuant to a tender of shares in a change of control transaction
V Transaction Voluntarily Reported
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust
Debug Info- Version: 2.6